Skip to main content
Local News

Translating Research to Treat Prostate Cancer

By April 3, 2019No Comments

A sun-lit Vancouver building houses a world-renowned team of scientists and researchers.

They are oncologists, medical geneticists, biologists, biophysicists and computer scientists – at the leading edge of cancer research. And each day they come to work with the goal of combatting the most prevalent cancer among Canadian men.

The Vancouver Prostate Centre (VPC) is a research hub hosted by UBC and the Vancouver Coastal Health Research Institute and the source of incredible innovation in translational prostate cancer research.

Dr. Martin Gleave, the VPC’s executive director and head of the UBC Faculty of Medicine’s Urologic Sciences department, is the chief architect of this environment.

Gleave, a UBC medical school alumnus, co-founded the VPC in 1998. It has since become one of the world’s most respected cancer research facilities. Gleave is also CEO of the Prostate Centre’s Translational Research Initiative for Accelerated Discovery and Development (PC-TRiADD), a national Centre of Excellence for Commercialization and Research.